KDR and neoplasm: VEGFR inhibitors have a synergistic effect with ICIs by enhancing tumor infiltration of immune cells and reducing the immuno‐suppressive effects of Tregs and myeloid‐derived suppressor cells (MDSCs) [431, 432, 433, 434, 435].